Xylem Balance Sheet Health
Financial Health criteria checks 6/6
Xylem has a total shareholder equity of $10.2B and total debt of $2.3B, which brings its debt-to-equity ratio to 22.2%. Its total assets and total liabilities are $15.9B and $5.7B respectively. Xylem's EBIT is $931.0M making its interest coverage ratio 35.8. It has cash and short-term investments of $947.0M.
Key information
22.2%
Debt to equity ratio
US$2.27b
Debt
Interest coverage ratio | 35.8x |
Cash | US$947.00m |
Equity | US$10.20b |
Total liabilities | US$5.72b |
Total assets | US$15.92b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XY6's short term assets ($3.9B) exceed its short term liabilities ($2.3B).
Long Term Liabilities: XY6's short term assets ($3.9B) exceed its long term liabilities ($3.4B).
Debt to Equity History and Analysis
Debt Level: XY6's net debt to equity ratio (13%) is considered satisfactory.
Reducing Debt: XY6's debt to equity ratio has reduced from 83.6% to 22.2% over the past 5 years.
Debt Coverage: XY6's debt is well covered by operating cash flow (41.6%).
Interest Coverage: XY6's interest payments on its debt are well covered by EBIT (35.8x coverage).